PT Kimia Farma Tbk Class B KAEF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.44
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 10,712
- Website
- https://www.kimiafarma.co.id
Comparables
Valuation
|
Metric
|
KAEF
|
EPMT
|
PALM
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 9.57 | — |
Price/Book Value | 0.77 | 0.94 | 1.13 |
Price/Sales | 0.44 | 0.22 | 20.32 |
Price/Cash Flow | 9.49 | 9.07 | — |
Price/Earnings
KAEF
EPMT
PALM
Financial Strength
|
Metric
|
KAEF
|
EPMT
|
PALM
|
|---|---|---|---|
Quick Ratio | 0.32 | 1.32 | 7.17 |
Current Ratio | 0.61 | 2.36 | 7.80 |
Interest Coverage | −2.80 | 65.19 | −7.54 |
Quick Ratio
KAEF
EPMT
PALM
Profitability
|
Metric
|
KAEF
|
EPMT
|
PALM
|
|---|---|---|---|
Return on Assets (Normalized) | −11.09% | 6.36% | −23.07% |
Return on Equity (Normalized) | −32.87% | 9.92% | −40.97% |
Return on Invested Capital (Normalized) | −9.95% | 9.46% | −22.82% |
Return on Assets
KAEF
EPMT
PALM
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Phmnrggq | Crqwpgd | $62.1 Bil | |||
| Cencora Inc
COR
| Bsbtcslb | Bqkmpn | $43.8 Bil | |||
| Cardinal Health Inc
CAH
| Ccjknrrc | Jvcpww | $26.3 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Fmrwpp | $9.0 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Kqszdb | $9.0 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Trbldz | $7.3 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Fpnxr | $7.3 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Nlbfzn | $6.6 Bil | |||
| Ebos Group Ltd ADR
EBOSY
| — | Djbznhc | $4.4 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Wrcp | $3.7 Bil |
United States